Release Date: 23/02/21 14:11 Summary: H1 FY21 Results Release Presentation Price Sensitive: Yes Download Document 8.3MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%